Literature DB >> 2696982

A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task.

E R Butelman1.   

Abstract

N-Methyl-d-aspartate (NMDA) receptors have been implicated with the triggering of long-term potentiation, a currently studied physiological model of learning and memory. The compound (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine maleate (MK-801) has recently been classified as a potent and selective NMDA antagonist acting at the associated ion channel. After determination of the highest intraperitoneal dose of MK-801 at which increases in activity (measured in photocell activity cages and 3-arm maze) were not observed (0.2 mg/kg), rats that had been previously trained to obtain food pellets in an 8-arm radial maze up to criterion were tested with 0.1 and 0.2 mg/kg doses. Dose-related decreases in "efficiency" in the task were found. The present findings support the suggestion that NMDA antagonists cause impairments in "working memory" and also support the status of long-term potentiation as a physiological model of memory.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2696982     DOI: 10.1016/0091-3057(89)90345-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  18 in total

1.  Subtle effects of ketamine on memory when administered following stimulus presentation.

Authors:  David J LaPorte; Teresa A Blaxton; Tamara Michaelidis; Donald U Robertson; Martin A Weiler; Carol A Tamminga; Adrienne C Lahti
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

2.  Comparison of error patterns produced by scopolamine and MK-801 on repeated acquisition and transition baselines.

Authors:  J Cohn; J M Ziriax; C Cox; D A Cory-Slechta
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice.

Authors:  D J Sanger; D Joly
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Behavioural studies with a newly developed neuroprotective KYNA-amide.

Authors:  Levente Gellért; Dániel Varga; Marian Ruszka; József Toldi; Tamás Farkas; István Szatmári; Ferenc Fülöp; László Vécsei; Zsolt Kis
Journal:  J Neural Transm (Vienna)       Date:  2011-08-05       Impact factor: 3.575

5.  Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.

Authors:  Andrea M Bradford; Kevin M Savage; Declan N C Jones; Mikhail Kalinichev
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

6.  Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.

Authors:  Alexandra E Smith; Zhili Xu; Yvonne Y Lai; Pushkar M Kulkarni; Ganesh A Thakur; Andrea G Hohmann; Jonathon D Crystal
Journal:  Behav Brain Res       Date:  2016-02-22       Impact factor: 3.332

7.  Long-lasting effects of repeated ketamine administration in adult and adolescent rats.

Authors:  M L Shawn Bates; Keith A Trujillo
Journal:  Behav Brain Res       Date:  2019-04-26       Impact factor: 3.332

8.  Immediate and long-term effects of neonatal MK-801 treatment on nonspatial learning.

Authors:  G S Griesbach; A Amsel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

9.  Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.

Authors:  Jason K Clark; Matthew Furgerson; Jonathon D Crystal; Marcus Fechheimer; Ruth Furukawa; John J Wagner
Journal:  Neurobiol Learn Mem       Date:  2015-09-15       Impact factor: 2.877

10.  Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats.

Authors:  B J Cole; M Klewer; G H Jones; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.